Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cephalon Is First Company To Release Physician Payments Under Consent Decree

This article was originally published in The Pink Sheet Daily

Executive Summary

The company, which does not cap its physician payments, paid 937 doctors for consulting and speaking services in 2009; its top-paid physician earned $149,900.

You may also be interested in...



Pfizer Is First Company To Post Clinical Trial Payments

Under a corporate integrity agreement, the firm's disclosures of payments to healthcare professionals include expenditures on research.

Pfizer Is First Company To Post Clinical Trial Payments

Under a corporate integrity agreement, the firm's disclosures of payments to healthcare professionals include expenditures on research.

GlaxoSmithKline's Top Speaker Earned $99,375 in Second Quarter

GlaxoSmithKline paid 3,700 U.S. physicians and other health care professionals $14.6 million during the second quarter of 2009. While GSK doled out less money than Lilly over a three-month period, its top recipients earned far more

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel